Ruzasvir, Bemnifosbuvir Hemisulfate clinical trials

A Phase 2, Open-Label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects with Chronic Hepatitis C Virus (HCV) Infection

This study is testing two new medicines, bemnifosbuvir and ruzasvir, to see how well and how safely they treat chronic Hepatitis C infection. We want to find out if these medicines can clear the virus from people's bodies.